Business
CSL (ASX:CSL) share price heads lower on haemophilia B deal
The CSL Limited (ASX: CSL) share price is slightly lower today despite announcing plans to buy rights for novel late-stage gene therapy candidate.
In late afternoon trade, the global biotech’s shares are swapping hands for $276.06, down 0.5%.
What did CSL announce?
Investors appear…
Continue Reading
-
Noosa News23 hours agoTwo people fighting for life as car and caravan crash into creek off Bruce Hwy
-
Noosa News24 hours agoConvicted murderer Allyn John Slater wrote ‘sadistic’ abuse stories while in prison for killing eight-year-old Trinity Bates
-
General22 hours agoLarissa Waters chosen as new Greens leader
-
Noosa News22 hours agoAustralia’s first home-grown rocket not ready for lift-off — yet